A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

The TREM2 receptor may hold the keys to understanding how myeloid cells affect immune responses to neurological disorders and cancer. Triggering receptors expressed on myeloid ... adipose tissue, skin ...

Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving remission.